Integrated proteomic and immune subtyping: a two-tier framework for biomarker-guided therapy in high-grade serous ovarian cancer
eBioMedicine · 2026-06 · 128 · 106295
DOI: 10.1016/j.ebiom.2026.106295 ↗Kurz gefasst
Fachartikel in der Zeitschrift eBioMedicine, 2026-06. Verfasst von Jiagui Song und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center of Peking University Third Hospital, Beijing 100191, China; Center of Basic Medical Research, Institute of Medical Innovation and Resea…. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Cancer Center of Peking University Third Hospital, Beijing 100191, China; Center of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China; Beijing…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Song, J., & Xue, L. (2026). Integrated proteomic and immune subtyping: a two-tier framework for biomarker-guided therapy in high-grade serous ovarian cancer. eBioMedicine, 128, 106295. https://doi.org/10.1016/j.ebiom.2026.106295
Vancouver
Song J, Xue L. Integrated proteomic and immune subtyping: a two-tier framework for biomarker-guided therapy in high-grade serous ovarian cancer. eBioMedicine. 2026;128:106295. doi:10.1016/j.ebiom.2026.106295
BibTeX
@article{Song2026,
author = {Song, Jiagui and Xue, Lixiang},
title = {Integrated proteomic and immune subtyping: a two-tier framework for biomarker-guided therapy in high-grade serous ovarian cancer},
journal = {eBioMedicine},
year = {2026},
volume = {128},
pages = {106295},
doi = {10.1016/j.ebiom.2026.106295}
}
EUVIMED